温和女人
发表于 2025-3-23 10:47:20
https://doi.org/10.1007/978-3-642-24070-6liferative signals. Although imatinib is an effective frontline therapy that has provided a remarkable success in the treatment of CML, the resistance to the inhibitor is still an obstacle. Quiescent leukemic stem cells are unresponsive to imatinib. BCR-ABL-dependent and BCR-ABL-independent mechanis
mastopexy
发表于 2025-3-23 14:38:31
http://reply.papertrans.cn/23/2250/224970/224970_12.png
EWE
发表于 2025-3-23 18:13:05
http://reply.papertrans.cn/23/2250/224970/224970_13.png
RAGE
发表于 2025-3-24 02:14:53
Harald Atmanspacher,Thomas Filkntional chemotherapy for patients with relapsed/refractory ALL showed better objective response. This review summarizes the clinical efficacy and safety of INO in the treatment of relapsed/refractory ALL, based on currently available data in the literature.
Blasphemy
发表于 2025-3-24 04:36:56
http://reply.papertrans.cn/23/2250/224970/224970_15.png
窝转脊椎动物
发表于 2025-3-24 08:26:16
http://reply.papertrans.cn/23/2250/224970/224970_16.png
招待
发表于 2025-3-24 11:29:45
https://doi.org/10.1007/978-3-642-25316-4y in both untreated APL patients and relapsed patients who have been treated with ATRA and chemotherapy. Retinoids are a model of the development of new molecular-targeted agents for other malignant tumors.
凹槽
发表于 2025-3-24 17:35:29
http://reply.papertrans.cn/23/2250/224970/224970_18.png
obsolete
发表于 2025-3-24 20:32:52
http://reply.papertrans.cn/23/2250/224970/224970_19.png
BARB
发表于 2025-3-25 01:28:48
http://reply.papertrans.cn/23/2250/224970/224970_20.png